Skip to main content

          -  U.S. Department of Health & Human Services 

            - Virtual Tour
            - Staff Directory
            - En Español

## Site Menu

-  Home 
-  Health Information  - Health Care Providers & Facilities
- Health Info Lines
- HealthCare.gov
- Science Education Resources
- NIH Clinical Research Trials and You
- Talking to Your Doctor

More »

Search Health Topics

Quick Links
- MedlinePlus Health Info
- NIH News in Health
- Wellness Toolkits
 
-  Grants & Funding  - Grants Home Page
- Find Funding
- Due Dates
- How to Apply
- About Grants
- Policy & Compliance
- Grants News/Blog
- Contracts
- Loan Repayment

More »

Quick Links
- RePORT
- eRA Commons
- NIH Common Fund
 
-  News & Events  - News Releases
- Digital Media Kits
- Media Resources
- Media Contacts
- Images and B-roll
- Events
- Social Media

More »

Quick Links
- NIH News in Health
- NIH Research Matters
- NIH Record
 
-  Research & Training  - Medical Research Initiatives
- Science Highlights
- Science Education
- Research in NIH Labs & Clinics
- Training Opportunities
- Library Resources
- Research Resources
- Clinical Research Resources
- Safety, Regulation and Guidance

More »

Quick Links
- PubMed
- Stem Cell Information
- OppNet
- NIDB
- NIH Blueprint for Neuroscience Research
 
-  Institutes at NIH  - List of Institutes and Centers
- NIH Office of the Director
- Directors of NIH Institutes and Centers
- NIH Institute and Center Contact Information

More »

Quick Links
- NCI
- NEI
- NHLBI
- NHGRI
- NIA
- NIAAA
- NIAID
- NIAMS
- NIBIB
- NICHD
- NIDCD
- NIDCR
- NIDDK
- NIDA
- NIEHS
- NIGMS
- NIMH
- NIMHD
- NINDS
- NINR
- NLM
- CC
- CIT
- CSR
- FIC
- NCATS
- NCCIH
 
-  About NIH  - Who We Are
- What We Do
- Jobs at NIH
- Visitor Information
- Frequently Asked Questions
- Contact Us

More »

Quick Links
- The NIH Director
- Take the Virtual Tour
- NIH...Turning Discovery Into Health®
- Impact of NIH Research
- Science, Health, and Public Trust
 

## You are here

HomeInstitutes at NIHNIH Office of the DirectorOffice of Communications & Public LiaisonFreedom of Information Act Office

## Freedom of Information Act Office

### Freedom of Information Act Office

                - Submitting FOIA Requests
                - Financial Disclosure Reports
                - Appeals
                - Fees
                - FOIA Requester Service Centers and FOIA Public Liaisons
                - Exemptions and Exclusions
                - NIH FOIA Library
                - Reference Guide
                - Publicly Available Information
                - Other Public Information Servers
                - Major Information Systems
                - FOIA Policies
                - Contact

# NIH FOIA Library

### On-Site Records

The NIH On-Site FOIA Library (**FL**) contains a variety of records that come from several of the Institutes and Centers at the NIH. The records are indexed with an identifying number to assist users in locating the record(s) of interest. The **Index of Records** is available at this site for your convenience. The records are available for reviewing in the **FL**, which is located in Building 31, Room 5B-35. The hours of operation are 10:00 a.m. to 4:00 p.m., Monday through Friday (closed on Federal holidays). A copy machine is available for users to duplicate records of particular interest. Please contact the FOIA Office to make arrangements to view one or more of these records.
                    - Index of Records

In addition, the following records are available in electronic format at this site:

### Electronic Records

### Past productions of fluoride records *

                        -  Production to a member of the public in response to FOIA request #59447 – emails from the CDC, FDA, NIDCR, NIH leadership, and HHS Assistant Secretary of Health that expressed concerns about the NTP fluoride monograph and a May 2022 publication date.                            -  Production 1 
                        -  Production to a member of the public in response to FOIA request #58947 – emails about fluoride between NIDCR employees and non-government persons sent to or received between August 1, 2020 and September 8, 2022.                            - Tranche 1 ,  Tranche 2 ,  Tranche 3 ,  Tranche 4 ,  Tranche 5 ,  Tranche 6 ,  Tranche 7 ,  Tranche 8 ,  Tranche 9 ,  Tranche 10 ,  Tranche 11 ,  Tranche 12 
                        -  Production to a member of the public in response to FOIA request #59250 – emails sent to or from Lawrence Tabak between April 26, 2022 and July 26, 2022 that include one or more of the following terms: NTP, National Toxicology Program, fluoride.                            - Tranche 1 ,  Tranche 2 

### Past productions of COVID-19 records *

                          -  Production to Jimmy Tobias in response to FOIA 59644 – Grant entitled, “RBD recombinant protein-based SARS vaccine for biodefense”                              - Tranche 1 ,  Tranche 2 ,  Tranche 3 ,  Tranche 4 ,  Tranche 5 ,  Tranche 6 ,  Tranche 7 ,  Tranche 8 
                          -  Production to Informed Consent Action Network in response to FOIA Request # 54464 – Safety Data regarding mRNA-1273 as of June 2, 2020:                              -  Tranche 1, Tranche 2, Tranche 3, Tranche 4 
                          -  Production to Informed Consent Action Network in response to FOIA Request # 54106 - Sent emails from Dr. Fauci from November 1, 2019 through January 31, 2020, that mention “SARS-CoV”, “COVID”, "Coronavirus" or "COVID-19". The remainder of the records produced to ICAN, from February 1 – May 5, are available in the Buzzfeed production, referenced below:                              -  Tranche 1, Tranche 2A, Tranche 2B, Tranche 3A, Tranche 3B 
                          -  Production to Buzzfeed in response to FOIA Request # 53768 - Sent emails from Dr. Fauci between February 1, 2020 through May 5, 2020, that mention "Coronavirus" or "COVID-19":                              -  Tranche 1A, Tranche 1B, Tranche 2A, Tranche 2B, Tranche 2C, Tranche 3A, Tranche 3B, Tranche 3C, Tranche 3D, Tranche 4A, Tranche 4B, Tranche 4C, Tranche 5A, Tranche 5B, Tranche 6A, Tranche 6B, Tranche 7A, Tranche 7B, Tranche 8A, Tranche 8B, Tranche 8C, Tranche 9A, Tranche 9B, Tranche 10A, Tranche 10B, Tranche 11A, Tranche 11B 
                          - Production to NPR in response to FOIA Request # 53738 – Emails from Drs. Fauci, Auchincloss, Lane, Handley, Morens, Mr. Folkers and Ms. Doepel, that include the terms: coronavirus, severe acute respiratory syndrome coronavirus 2, Wuhan, 2019-nCoV, SARS-CoV-2 or COVID-19, from 12/1/19 through 1/31/20.					                             -  7/31/2021 Production - Tranche 1, Tranche 2, Tranche 3, Tranche 4, Tranche 5, Tranche 6 
                            -  8/31/2021 Production - Tranche 1, Tranche 2, Tranche 3, Tranche 4, Tranche 5 

### Past productions of EcoHealth Alliance records *

                          - Production  to a freelance journalist in response to FOIA Request # 56372 containing written communications between Dr. Fauci and EcoHealth Alliance between January 1, 2020 and May 24, 2021.
                          - Production to US Right to Know in response to FOIA Request # 56010 containing documents and correspondence between NCBI and the authors of the Bat betacoronavirus isolate 7896 RNA-dependent RNA polymerase (RdRp) gene dataset between August 19, 2019 and June 30, 2020.  The format of these records is such that they are too large to post. Specifically, the files contain large amounts of unintelligible computer code. They are available upon request.
                          - Production  to a member of the public in response to FOIA Request # 56444 containing email correspondence between Dr. Fauci and Peter Daszak from October 1, 2019 through May 30, 2020.
                          - Production  to Just the News in response to FOIA Request # 56215 containing all emails between Dr. Fauci and Peter Daszak from January 1, 2014 through January 1, 2021.
                          -  Production to Washington Free Beacon in response to FOIA Request # 56433, all emails from Hugh Auchincloss containing the words “gain of function”, “lab” and “China”, and all correspondence between Dr. Auchincloss and Peter Daszak and Dr. Ralph Baric between 9/1/2020 and 6/03/2021. 
                          - Interim Research Performance Progress Report for Grant R01Al110964-05 Understanding the Risk of Bat Coronavirus Emergence 8/03/21 and Research Performance Progress Report for Grant R01Al110964-05 Understanding the Risk of Bat Coronavirus Emergence 4/13/21
                          - Production to The Intercept in response to FOIA Request # 55058 - complete grant (all six years) for R01AI110964, EcoHealth Alliance’s “Understanding the Risk of Bat Coronavirus Emergence was sent to Judicial Watch”:					                             -  Year 1 (Tranche 1, Tranche 2, Tranche 3, Tranche 4), Year 2, Year 3, Year 4, Year 5, Year 6 (Tranche 1, Tranche 2, Tranche 3, Tranche 4, Tranche 5) 
                          - Production to The Intercept in response to FOIA Request # 55058 - complete grant for U01AI151797, EcoHealth Alliance’s “Understanding Risk of Zoonotic Virus Emergence in EID Hotspots of Southeast Asia.”					                             - Tranche 1 ,  Tranche 2 ,  Tranche 3 ,  Tranche 4 ,  Tranche 5 ,  Tranche 6 ,  Tranche 7 ,  Tranche 8 ,  Tranche 9 ,  Tranche 10 

### Other Electronic Records

                          - NIH Response to Murray and DeLauro Letters regarding Sexual Harassment
                          - Listing of Firearm Related Research Supported by NIH from Fiscal Years 2020 (One-Time Analysis)
                          - Listing of Firearm Related Research Supported by NIH from Fiscal Years 1996-2015 (One-Time Analysis)
                          - ​ Letter from Senior Clinical Center Department Heads and Distinguished Senior Scientist regarding the Red Team Report
                          - Memorandum of Understanding between the Foundation for the National Institutes of Health, Inc, and the NIH Office of the Director for the Sports and Health Research Program
                          - Report on Investigation of Allegations of Noncompliance with the Public Health Service Policy on Humane Care and Use of Laboratory animals at Primate Products Inc.
                          - NIH’s Response to the April 7, 2015, letter from Chairman Bryant of the National Capital Planning Commission regarding the NIH Master Plan
                          - NIH’s Response to the March 12, 2015, letter from Councilmember Roger Berliner regarding the NIH Master Plan
                          - NIH Quality Audit Report of University of Texas Medical Branch at Galveston, February 20, 2015, Study Number STDY-13-0005-TG, “Infectivity and Lethality of Marburg Virus Angola in Non-human Primates Following Intramuscular Challenge
                          - Animal Welfare Investigation — Animal Welfare Assurance A4149-01 [Case 9Y] (nonhuman primate studies conducted at an NIH intramural lab)
                          - Letters from Francis S. Collins, Director, NIH, to Representatives Lucille Roybal-Allard, Dina Titus, Eliot Engel and Sam Farr regarding the Animal Welfare Investigation — Animal Welfare Assurance A4149-01[Case 9Y] (nonhuman primate studies conducted at an NIH intramural lab)
                          - Report on Investigation of Allegations of Noncompliance with the Public Health Service Policy on Humane Care and Use of Laboratory Animals at the University of Wisconsin-Madison
                          - Report on Investigation of Allegations of Noncompliance with the Public Health Service Policy on Humane Care and Use of Laboratory Animals at the University of Texas Medical Branch
                          - Records related to the HeLa Genome					                             - Data Use Agreement
                            - Summary of the Data Use Agreement
                            - HeLa Genome Access Working Group 
                          - Letter from Dr. Francis S. Collins, Director, NIH, to Chairman, Committee on Energy and Commerce regarding NIH’s communications and public education efforts (June 24, 2013)
                          - Records regarding certain studies being conducted by the Eunice Kennedy Shriver National Institute of Child Health and Human Development’s Neonatal Research Network
                          - NIH's Response to the February 14, 2012, letter from Representatives Henry Waxman, Edward Markey and Dianna DeGette regarding the Reporting of Phase IV Trial Results in clinicaltrials.gov
                          - PWG Reports for Ramazzini Institute Studies:					                             - Pathology QA Review and PWG Coordinator's Report for Ramazzini Institute Acrylonitrile Studies
                            - Pathology QA Review and PWG Coordinator's Report for Ramazzini Institute Ethyl-tertiary-butyl Ether
                            - Pathology QA Review and PWG Coordinator's Report for Ramazzini Institute Vinyl Chloride
                            - Pathology QA Review and PWG Coordinator's Report for Ramazzini Institute Methyl-tertiary-butyl Ether Studies
                            - Pathology QA Review and PWG Coordinator’s Report for Ramazzini Institute Methyl Alcohol Studies 
                          - NIH Diversity Report — Public Dataset
                          - NIH Stem Cell Funding Information
                          - Organization Charts
                          - March-in Determination in The Case of Fabrazyme®
                          - Conflict of Interest Information and Resources
                          - Historical Documents Related to the Council of Public Representatives
                          - FOIA Annual Reports

### Administrative Staff Manuals

                        - NIH Manual Chapters

### Frequently Requested Records

                        - Public Comments in Response to a June 2023 Federal Register Notice To Announce NIH Updated Policy Guidance for Subaward/Consortium Written Agreements
                        - NIH FOIA Log
                        - NIH Procurement-Related Information
                        - Selected Institute and Center Directors' Meeting Highlights
                        - CellPro Documents
                        - Contact Information for NIH-Supported Principal Investigators
                        - **NIH Telephone Directory**

An NIH Search is available.

* New productions will be added on a rolling basis. This content is in the process of Section 508 review. If you need immediate assistance accessing this content, please submit a request to nihfoia@od.nih.gov. Content will be updated pending the outcome of the Section 508 review.

This page last reviewed on September 13, 2023

## Connect with Us

              - Contact Us
              - X
              - Facebook
              - Instagram
              - YouTube
              - Flickr
              - More Social Media from NIH

## Footer

- NIH Home
- Virtual Tour
- En Español
- Visitor Information
- Frequently Asked Questions
- Privacy Policy
- Disclaimers
- Accessibility
- NIH Website Archives

- Nondiscrimination Notice
- Freedom of Information Act
- No Fear Act
- HHS Vulnerability Disclosure
- Office of Inspector General
- USA.gov

NIH...Turning Discovery Into Health®

National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892

U.S. Department of Health and Human Services

Back to Top